Showing results (21-30 of 128) with videos related to
Sort By:
Pageof 13
Neuroscience Letters|October 19, 2004
Expression of MATH1, a marker of cerebellar granule cell progenitors, identifies different medulloblastoma sub-typesEttore Salsano, Bianca Pollo, Marica Eoli, et al.Journal of Immunology Research|May 18, 2017
MRI in Glioma Immunotherapy: Evidence, Pitfalls, and PerspectivesDomenico Aquino, Andrea Gioppo, Gaetano Finocchiaro, et al.Scientific Reports|September 9, 2016
Ultrasonic Surgical Aspirate is a Reliable Source For Culturing Glioblastoma Stem CellsJinan Behnan, Biljana Stangeland, Tiziana Langella, et al.Expert Review of Molecular Diagnostics|October 13, 2009
Genetic signature of adult gliomas and correlation with MRI featuresMaria Grazia Bruzzone, Marica Eoli, Valeria Cuccarini, et al.Cancer Immunology, Immunotherapy : CII|July 23, 2011
A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironmentGabriele Cantini, Federica Pisati, Alfonso Mastropietro, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 2, 2012
Central nervous system lymphoma occurring in a patient with neurofibromatosis type 1 (von Recklinghausen disease)Marica Eoli, Donata Bianchessi, Anna Luisa Di Stefano, et al.Molecular and Cellular Neurosciences|August 25, 2009
Reelin affects chain-migration and differentiation of neural precursor cellsSimone Massalini, Serena Pellegatta, Federica Pisati, et al.Cell Death & Disease|August 11, 2017
Identification and characterization of a new source of adult human neural progenitorsJinan Behnan, Biljana Stangeland, Tiziana Langella, et al.Oncoimmunology|July 29, 2016
The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant gliomaSara Pessina, Gabriele Cantini, Dimos Kapetis, et al.International Journal of Molecular Sciences|November 28, 2019
ABCC3 Expressed by CD56dim CD16+ NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell ImmunotherapySerena Pellegatta, Natalia Di Ianni, Sara Pessina, et al.Pageof 13